Correction: The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol

• Noa Bregman,
• Tamara Shiner,
• Gitit Kavé,
• Roy Alcalay,
• Mali Gana-Weisz,
• Orly Goldstein,
• Tal Glinka,
• Orna Aizenstein,
• Dafna Ben Bashat,
• Yifat Alcalay,
• Anat Mirelman,
• Avner Thaler,
• Nir Giladi,
• Nurit Omer

Affiliations

Noa Bregman

Cognitive Neurology Unit, Neurological Institute, Tel-Aviv Medical Center

Tamara Shiner

Cognitive Neurology Unit, Neurological Institute, Tel-Aviv Medical Center

Gitit Kavé

Cognitive Neurology Unit, Neurological Institute, Tel-Aviv Medical Center

Roy Alcalay

Laboratory of biomarkers and genomic of neurodegeneration, Tel-Aviv Medical Center

Mali Gana-Weisz

Laboratory of biomarkers and genomic of neurodegeneration, Tel-Aviv Medical Center

Orly Goldstein

Laboratory of biomarkers and genomic of neurodegeneration, Tel-Aviv Medical Center

Tal Glinka

Laboratory of biomarkers and genomic of neurodegeneration, Tel-Aviv Medical Center

Orna Aizenstein

Sagol Brain Institute, Wohl Institute for Advanced Imaging, Sourasky Medical Center

Dafna Ben Bashat

Sagol School of Neuroscience, Tel-Aviv University

Yifat Alcalay

Sackler School of Medicine, Tel-Aviv University

Anat Mirelman

Sackler School of Medicine, Tel-Aviv University

Avner Thaler

Sackler School of Medicine, Tel-Aviv University

Nir Giladi

Sackler School of Medicine, Tel-Aviv University

Nurit Omer

Cognitive Neurology Unit, Neurological Institute, Tel-Aviv Medical Center